This message was sent to ##Email##
Registration for the ASHI 43rd Annual Meeting being held at the Hilton San Francisco Union Square on September 11-15, 2017 is now open!
Register by Thursday, July 20th to take advantage of our early registration rates.
Click here to view the program.
Click here to download the complete registration brochure!
Click here to view more information regarding registration rates and how to register today!
Book Your Hotel Now!
Housing is now available for the ASHI 43rd Annual Meeting in San Francisco. Housing is available on a first-come, first-served basis. Book your housing today to guarantee your room!
Click here for more information on hotel room rates and how to book online.
Song Requests Welcome!
There is a NEW Networking Event this year at the ASHI 43rd Annual Meeting. For those of you who "work hard – party hard" we will have a Desserts and Dancing evening with Dorry Segev on Thursday, September 14 at 9:00 PM. Dorry is a transplant surgeon from John Hopkins Medical Center who has been a DJ at several transplant-related, highly enjoyable parties. Dorry will be collecting requests for songs over the next few months and he will lead our party on Thursday evening. This event is included in the meeting registration fee and there is no additional charge to attend this event!
See you at the Networking Event!
Thursday, September 14, 2017
9:00 PM - 11:00 PM
Click here to submit a song request!
|Regional Educational Workshop 2 — Space is still Available!
The preliminary program for the ASHI Regional Education Workshop 2 is now available! Click here to view the preliminary program.
Regional Workshop 2 Keynote Address: Dr. Joren Madsen
Join us Thursday evening for the Regional Workshop 2 Welcome Reception and Keynote Address, Dr. Joren Madsen from Massachusetts General Hospital, from 6:30 - 8:30 pm in the Rosemore Ballroom.
Dr. Joren C. Madsen, the Paul S. Russell/Warner-Lambert Professor of Surgery at Harvard Medical School, is a heart transplant surgeon with a strong research interest in transplant immunology. He is currently the director of the MGH Transplant Center and co-director of the MGH Center for Transplantation Sciences.
Make Hotel Reservation
The next generation of Virtual Crossmatch is here!
VXmatch is a web and mobile-enabled application that displays all the crossmatch data you want; in exactly the way you want it. Want DSA trends, dilution, reactivity history, and graphs? VXmatch is a virtual crossmatch for labs who take it seriously.
The Travel Fund Award was created to help newer ASHI members attend regional and annual meetings. For the Annual meeting, two grants have been reserved for Technologist members and two for Doctoral level members. Winners of a 2017 ASHI Travel Fund Award will receive:
|ASHI Travel Awards Available — Apply Now!
*Limited to one travel fund award per institution each year.
- One (1) complimentary registration to the 2017 ASHI Annual Meeting
- Up to $1,000 reimbursement to the 2017 Annual Meeting (must be in compliance with the ASHI travel policy).
To be considered for the ASHI Travel Fund Award you must be a current ASHI member of five (5) years or less. The following increase your likelihood of being chosen:
Please complete this application. Once we receive your application, we will contact your General Supervisor or Director for verification of support for your application. These items will be sent to the reviewing committee. Good luck!
- Volunteer service to ASHI and/or ABHI
- Presentations at ASHI meetings
- Authorship in ASHI publications
- Desire to further your career in HLA
APPLICATION DEADLINE is July 7, 2017
Result submission for the AC-1 survey is due on May 19, 2017. If your lab has not yet submitted your survey results in the lab center, please do so today by logging in here.
The EMO survey was shipped on May 9th. The results submission due date for this survey is June 9, 2017.
Take a few moments to renew your 2017 ASHI membership today to avoid disruption of your ASHI benefits. Your membership dues allow us to provide programs, professional awards, and educational opportunities that advance the science, education and application of immunogenetics and transplant immunology. Renew Online Today!
|Don't Let Your ASHI Membership Expire!
The ASHI Distinguished Service Award was established in 1999 to honor colleagues who have contributed significantly to ASHI's heritage. This award recognizes:
The ASHI Distinguished Scientist Award was established in 2001 to honor a distinguished scientist who is an ASHI member. This individual must have contributed significantly to the field of immunogenetics and/or transplant immunology. This award recognizes:
- ASHI membership past or present, doctoral or non-doctoral
- Creativity in moving ASHI in new directions, both scientifically and as an organization
- Service to ASHI
- Educational contribution on behalf of ASHI
The Rose Payne Award recognizes distinguished scientific accomplishment and extraordinary contributions to the immunogenetics community. Specifically, this award recognizes contributions to the advancement of histocompatibility and immunogenetics and other extraordinary contributions.
- ASHI membership past or present
- Professional scientific accomplishments: theoretical and technical creativity
- Special contributions and achievements in their field of expertise
- Other extraordinary contributions
The Outstanding Technologist Award is presented annually to a technologist who has provided outstanding contributions to the field of histocompatibility and immunogenetics.
Click here to read the nomination requirements for all awards and then submit your nominations now to Katherine Miranda.
THE NOMINATIONS DEADLINE IS JUNE 1, 2017.
To view a list of former award winners, please click here.
Are you a technologist who has worked in the HLA field for less than three years? Are you looking forward to a career in HLA? By sharing your HLA story with us, you could win ASHI's 2017 Rising Star Award!
The Rising Star Award recognizes an outstanding HLA technologist who has worked in the field for less than three years and desires to pursue a career in HLA. The requirement for this award is a short essay (less than four pages) describing your current work in HLA and why you are interested in pursuing a career in the field. This essay must be written by you, the nominee, and validated by your director or direct supervisor.
The winner will receive:
To be considered for this year's Rising Star Award, submit your essay by June 1, 2017 to Katherine Miranda at ASHI Headquarters.
- One (1) complimentary registration to the 2017 ASHI Annual Meeting in San Francisco
- Two (2) nights hotel stay at the Hilton San Francisco Union Square
- Up to $700 airfare in compliance with the ASHI travel policy
- A plaque which will be presented to you at the ASHI Annual Meeting during the Awards & Business Meeting
- One (1) year ASHI technologist membership. If you are already an ASHI member, your membership will be extended for one year.
To view former award winners, please click here.
The latest release of the 17th International Histocompatibility & Immunogenetics Workshop and Conference newsletter, IHIWS Connects, is now available. This issue features registration instructions for attending the 17th IHIWS in Pacific Grove, California, as well as important updates about the progress of workshop components and projects. To read this and all prior IHIWS Connects newsletters, visit: http://ihiws.org/newsletters/
Elsevier, publisher of ASHI's scientific publication, Human Immunology, offers online education to authors. Here you'll find free online lectures, interactive training courses, expert advice and other resources to support you in publishing your journal article or world-class book. Certificates to recognize your efforts are available.
Name & Credentials: Nicholas DiPaola PhD, D(ABHI)
Job title and place of employment: Medical Director Histocompatibility, Houston Methodist Hospital
Graduated from: University of Toledo (formerly Medical College of Ohio)
How long have you been an ASHI member? Since 2005 (~12 years)
If you would like to be featured in an upcoming Member Spotlight, please complete the online form.
ASHI and the Association of Medical Laboratory Immunologists (AMLI) are hosting an exciting Member Society symposium at the 17th Annual Meeting of the Federation of Clinical Immunology Societies (FOCIS 2017) on Wednesday, June 14, at the Hilton Downtown Chicago Hotel. First held in 2001, the FOCIS Annual Meeting draws the best clinician scientists from around the world to participate in the scientific program, bringing together cutting-edge science from various disease fields related to clinical immunology.
With an innovative lineup of topics and presenters, the FOCIS 2017 program has something for everyone! Registration is open and travel awards are available to top-scoring late-breaking posters.
Hope to see you in Chicago!
The 2017 International Summer School meeting, jointly sponsored and produced by EFI, ASHI, and APHIA, will be held at Trinity College in the heart of the city of Dublin, Ireland, July 24-26th, 2017.
The International Summer School (ISS) provides a focused course on all aspects of theoretical and applied immunogenetics and histocompatibility. To encourage discussion, the course is limited to a small number of participants (30-40). Participants are invited to present their own research. This meeting is a great opportunity for those seeking higher education in histocompatibility and immunogenetics as well as a chance to meet others working in the field from different parts of the world.
ASHI will be awarding two travel stipends to attend the International Summer School. If you are an ASHI member, please contact us for an ISS application at firstname.lastname@example.org.
Click here for more information!
44TH ANNUAL MEETING
October 1-5, 2018
Baltimore Marriott Waterfront
45TH ANNUAL MEETING
September 23-27, 2019
David L. Lawrence Convention Center
46TH ANNUAL MEETING
October 19-23, 2020
You must log in to access the members only Forums.
If you would like to receive updates as content is posted, you must subscribe by clicking the Forum Actions Box at the top of the Forum page and subscribe to instant updates or/and click to subscribe to the Digest to get updates.
Click here for detailed instructions
Why not join the conversation? Login here.
Current Forum topics being discussed include:
- HLA Laboratory Business Model
- Complement binding antibodies and 1:16 serum dilution
- DP Antibody in Heart Tx
- SAB Testing
- Contacting Patients for Serum Specimens
- What current challenges are you facing as a technologist?
- How did you get started in HLA?
American Journal of Transplantation
Solid organ transplant recipients have an elevated incidence of thyroid cancer. We evaluated a wide range of potential risk factors in a cohort of 229,300 U.S. solid organ transplant recipients linked with 15 stage/regional cancer registries (1987-2012). Incidence rate ratios (IRRs) were adjusted for age, sex, race/ethnicity, transplanted organ, year of transplant, and time since transplant. Hazards ratios (HRs) for death and/or graft failure were adjusted for age, sex, race/ethnicity, transplanted organ, and year of transplant.
The Mount Sinai Hospital / Mount Sinai School of Medicine via ScienceDaily
Immunotherapy, which has achieved remarkable results in late-stage lung cancer patients, can also hold great hope for newly diagnosed patients, cutting the deadly disease off before it has the chance to take hold and offering a potential cure, according to a new study.
After phase 1 results of Seattle Children's Pediatric Leukemia Adoptive Therapy (PLAT-02) trial have shown T-cell immunotherapy to be effective in getting 93 percent of patients with relapsed or refractory acute lymphoblastic leukemia (ALL) into complete initial remission, researchers have now opened a first-in-human clinical trial aimed at reducing the rate of relapse after the therapy, which is about 50 percent. The new phase 1 pilot study, PLAT-03, will examine the feasibility and safety of administering a second T-cell product intended to increase the long-term persistence of the patient's chimeric antigen receptor (CAR) T cells that were reprogrammed to detect and destroy cancer.
|Access to educational information is free to ASHI members. CECs are awarded through an online testing process and are free to ASHI members.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063